Ostomy - Hollister Premier One-Piece

Risk for incident atrial fibrillation was higher in those who habitually used fish oil supplementation compared with those who did not, researchers reported in the European Journal of Preventive Cardiology. Further, genetic AF predisposition, no diagnosis of CVD at baseline and background oily fish consumption did not change the association found between fish oil supplementation and AF risk, according to researchers. The general population should be informed of the potential AF risks with fish oil supplementation; and the physicians should balance the risk-benefit ratio with fish oil ...

>Read More

Stryker has announced FDA 510(k) clearance for its OptaBlate bone tumor ablation system for patients with metastatic cancer, according to a press release. The OptaBlate system is designed with microinfusion technology to keep the surgical area hydrated and help prevent charring, according to the release. Our commitment to our customers and understanding their needs has never been stronger. The collaboration has helped us to develop a more efficient bone tumor ablation system to address their unmet needs, Greg Siller, vice president and general manager of Strykers ...

>Read More

This years European Society for Medical Oncology Congress featured potentially practice-changing research in kidney cancer, cutaneous squamous cell carcinoma, lung cancer and melanoma. Healio presents the following updates from ESMO that may be relevant to your practice. 1. The addition of cabozantinib (Cabometyx, Exelixis) to nivolumab (Opdivo, Bristol Myers Squibb) and ipilimumab (Yervoy, Bristol Myers Squibb) conferred a significant PFS benefit among patients with advanced renal cell carcinoma. Read more. 2. Neoadjuvant cemiplimab (Libtayo; Regeneron Pharmaceuticals, Sanofi) induced ...

>Read More

In this Healio Video Perspective, Cynthia A. Matossian, MD, FACS, and David Evans, PhD, MBA, discuss making sure a practices online information is not outdated. It is important for physicians to research their own practice online to check the accuracy of the content that is presented, Evans said. After any incorrect or out-of-date information is fixed, practice owners should check the accuracy again every 1 to 2 months to ensure that any mistakes do not go unnoticed for long. ...

>Read More

Ironwood Pharmaceuticals Inc. announced positive results from its phase 3 trial that evaluated Linzess for the treatment of pediatric patients with functional constipation, according to a company press release. In a randomized, double-blind, parallel group study, 330 pediatric patients with functional constipation aged 6 to 17 years received either Linzess (linaclotide 72 mcg, AbbVie/Ironwood) or placebo. In a Healio interview exclusive, Susanna Huh, MD, MPH, head of clinical development and research for Ironwood Pharmaceuticals, said Linzess induced a statistically significant and ...

>Read More

Both men and women with HF faced higher risks for depression and death by suicide in the first 3 months after their diagnosis, researchers reported in JACC: Heart Failure. The large burden of disease associated with HF may potentially cause psychosocial distress that worsens suffering, quality of life and long-term health outcomes, Casey Crump, MD, PhD, vice chair for research in the department of family medicine and community health at Mount Sinai, and colleagues wrote. Previous evidence has shown that HF patients with psychosocial distress are more likely to struggle ...

>Read More

Zimmer Biomet Inc. has announced FDA 510(k) clearance of the Identity shoulder system for anatomic, reverse and revision shoulder replacement procedures, according to a company press release. The Identity shoulder system is compatible with a range of humeral and glenoid options to fit each patients unique anatomy, according to the release. The FDA clearance of the Identity shoulder system is exciting because it offers surgeons a highly adaptable solution for anatomic, reverse and revision procedures to help patients optimize natural shoulder movement, Ivan Tornos, chief ...

>Read More

Product Listings for Ostomy - Hollister Premier One-Piece